TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,723,184 | -21.8% | 364,302 | -17.9% | 0.02% | -34.8% |
| Q1 2023 | $7,314,648 | +0.7% | 443,850 | -20.8% | 0.02% | -23.3% |
| Q3 2022 | $7,265,000 | -8.7% | 560,150 | +28.0% | 0.03% | +130.8% |
| Q4 2020 | $7,955,000 | +44.3% | 437,500 | +42.3% | 0.01% | +18.2% |
| Q3 2020 | $5,511,000 | +5.5% | 307,500 | +6.0% | 0.01% | -38.9% |
| Q2 2020 | $5,224,000 | +6.0% | 290,000 | -10.8% | 0.02% | -14.3% |
| Q1 2020 | $4,928,000 | -46.1% | 325,000 | -29.7% | 0.02% | -40.0% |
| Q4 2019 | $9,147,000 | -15.9% | 462,500 | -26.3% | 0.04% | -14.6% |
| Q3 2019 | $10,879,000 | -50.9% | 627,500 | -50.0% | 0.04% | -19.6% |
| Q2 2019 | $22,178,000 | +67.7% | 1,255,000 | +94.6% | 0.05% | -7.3% |
| Q1 2019 | $13,224,000 | – | 645,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |